Clinical Trials

Study Title:
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High Risk Pancreatic Neuroendocrine Tumors

For more information about the trial above please contact the study team:

Principal Investigator, William Lancaster, at lancastw@musc.edu.

Study Coordinator, Carly Fecio, at fecio@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina